US Patent Litigations are now available. Check here

Explore patent oppositions filed by Neuraxpharm Arzneimittel against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 10, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2959894S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISMar 22, 2023
EP2653873Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MAJul 20, 2022
EP3103443Method For Treating Primary InsomniaNEURIM PHARMACEUTICALSMar 29, 2022